Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant.
<h4>Purpose</h4>To determine the characteristics of diabetic macular edema (DME) patients refractory to intravitreal bevacizumab (IVB) treatments and an additional dexamethasone implant.<h4>Methods</h4>We classified 119 DME patients according to whether or not they are respon...
Main Authors: | Moon Young Choi, Donghyun Jee, Jin-Woo Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0222364 |
Similar Items
-
Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment.
by: Jin-Woo Kwon, et al.
Published: (2018-01-01) -
Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
by: Serhad Nalçacı, et al.
Published: (2019-04-01) -
Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01) -
Early switch from anti-VEGF Therapy to dexamethasone implant in diabetic macular edema
by: R. R. Fayzrakhmanov, et al.
Published: (2021-01-01) -
The Efficacy of Single-Dose Intravitreal Dexamethasone Implant for Diabetic Macular Edema Refractory to Anti-VEGF Therapy: Real-Life Results
by: Mert Simsek, et al.
Published: (2020-02-01)